{"id":482237,"date":"2024-01-04T18:00:18","date_gmt":"2024-01-05T02:00:18","guid":{"rendered":"https:\/\/nai500.com\/?p=482237"},"modified":"2024-01-04T18:00:18","modified_gmt":"2024-01-05T02:00:18","slug":"%e5%88%86%e6%9e%90%e5%b8%88-%e7%9c%8b%e6%b6%a8-%e6%9c%a8%e5%a4%b4%e5%a7%90%e8%82%a1%e7%a5%a8-%e5%8c%bb%e7%96%97%e8%a1%8c%e4%b8%9a","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2024\/01\/%e5%88%86%e6%9e%90%e5%b8%88-%e7%9c%8b%e6%b6%a8-%e6%9c%a8%e5%a4%b4%e5%a7%90%e8%82%a1%e7%a5%a8-%e5%8c%bb%e7%96%97%e8%a1%8c%e4%b8%9a\/","title":{"rendered":"\u5206\u6790\u5e08\u4e00\u81f4\u770b\u6da8\u8fd98\u53ea\u6728\u5934\u59d0\u80a1\u7968\uff0c\u5176\u4e2d5\u53ea\u6765\u81ea\u533b\u7597\u884c\u4e1a"},"content":{"rendered":"<p>\u6728\u5934\u59d0\u7684\u57fa\u91d1ARK Innovation ETF\uff08ARKK\uff09\u4ece\u6765\u4e0d\u60e7\u8ddf\u534e\u5c14\u8857\u548c\u6807\u666e500\u6307\u6570\u5531\u53cd\u8c03\uff0c\u4f46\u6709\u4e9b\u65f6\u5019\uff0c\u8fd9\u4f4d\u79d1\u6280\u6295\u8d44\u4e00\u59d0\u8ddf\u5206\u6790\u5e08\u4e5f\u80fd\u8fbe\u6210\u4e00\u81f4\u610f\u89c1\u3002<\/p>\n<p>\u5c31\u6bd4\u5982\u8bf4\uff0c\u5206\u6790\u5e08\u8ba4\u4e3aARK Innovation\u76848\u53ea\u80a1\u7968\uff0c\u5305\u62ec<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=VERV\">Verve Therapeutics Inc\uff08NASDAQ:VERV\uff09<\/a>\u30012U Inc\uff08NASDAQ:TWOU\uff09\u548cIntellia Therapeutics Inc\uff08NASDAQ:NTLA\uff09\u7684\u80a1\u4ef7\u5c06\u5728\u672a\u676512\u4e2a\u6708\u4e0a\u6da850%\u53ca\u4ee5\u4e0a\u3002<\/p>\n<p>\u76f8\u6bd4\u4e4b\u4e0b\uff0c\u5373\u4f7f\u662f\u534e\u5c14\u8857\u6700\u4e50\u89c2\u7684\u5206\u6790\u5e08\uff0c\u4e5f\u53ea\u6562\u9884\u6d4b\u4eca\u5e74\u6807\u666e500\u6307\u6570\u5c06\u4e0a\u6da8\u7ea69%\u3002\u5206\u6790\u5e08\u5982\u6b64\u770b\u597d\u8fd9\u4e9b\u6728\u5934\u59d0\u80a1\u7968\uff0c\u5176\u4e2d\u591a\u6570\u90fd\u6765\u81ea\u4e8e\u533b\u7597\u677f\u5757\uff0c\u8fd9\u5f53\u4e2d\u8fd8\u662f\u900f\u9732\u51fa\u4e86\u4e00\u4e9b\u6709\u4ef7\u503c\u7684\u4fe1\u606f\u3002<\/p>\n<h2>\u6728\u5934\u59d0\u7684\u6295\u8d44\u98ce\u683c<\/h2>\n<p>\u6295\u8d44\u8005\u5982\u6b64\u6267\u7740\u4e8e\u6728\u5934\u59d0\u7684ARK Innovation\uff0c\u8fd9\u5176\u5b9e\u4e0d\u96be\u7406\u89e3\uff0c\u8fd9\u5b8c\u5168\u53d6\u51b3\u4e8e\u5979\u7684\u6295\u8d44\u98ce\u683c\u3002\u5728\u5e02\u573a\u884c\u60c5\u597d\u7684\u65f6\u5019\uff0c\u8fd9\u53ea\u57fa\u91d1\u603b\u80fd\u4e00\u98de\u51b2\u5929\u3002<\/p>\n<p>\u5c31\u62ff2023\u5e74\u6765\u8bf4\u3002\u8be5ETF\u53bb\u5e74\u7684\u603b\u6536\u76ca\u7387\u4e3a67.64%\uff0c\u662f\u7f8e\u56fd\u8868\u73b0\u6700\u597d\u7684\u4e3b\u52a8\u7ba1\u7406\u578b\u591a\u5143\u5316ETF\uff0c\u751a\u81f3\u8dd1\u8d62\u4e86Invesco Nasdaq 100 ETF\uff08QQQM\uff09\u768455.0%\uff0c\u540c\u671fSPDR S&amp;P 500 ETF Trust\uff08NYSE:SPY\uff09\u7684\u6536\u76ca\u7387\u53ea\u670926.2%\u3002\u5982\u679c2024\u5e74\u6807\u666e500\u6307\u6570\u518d\u5ea6\u8d70\u5f3a\uff0c\u6728\u5934\u59d0\u504f\u7231\u7684\u8fd9\u7c7b\u9ad8\u7206\u53d1\u529b\uff0c\u80a1\u4ef7\u5f39\u6027\u6781\u5927\u7684\u80a1\u7968\u81ea\u7136\u4f1a\u5438\u5f15\u6240\u6709\u4eba\u7684\u5173\u6ce8\u3002<\/p>\n<p>\u603b\u7684\u6765\u770b\uff0cARK Innovation\u768434\u53ea\u6301\u80a1\u5f53\u4e2d\uff0c\u591a\u6570\u4e2a\u80a1\u90fd\u88ab\u5206\u6790\u5e08\u770b\u597d\u3002\u4ed6\u4eec\u8ba4\u4e3a\u8fd9\u4e9b\u80a1\u7968\u7684\u4ef7\u683c\u672a\u676512\u4e2a\u6708\u5c06\u5e73\u5747\u4e0a\u6da8\u8fd130%\uff0c<\/p>\n<h2>\u533b\u7597\u80a1\u5360\u534a\u58c1\u6c5f\u5c71<\/h2>\n<table>\n<thead>\n<tr>\n<td><strong>\u516c\u53f8<\/strong><\/td>\n<td><strong>\u80a1\u7968\u4ee3\u7801<\/strong><\/td>\n<td><strong>\u80a1\u4ef7\u4e0a\u6da8\u7a7a\u95f4<\/strong><\/td>\n<td><strong>\u677f\u5757<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Verve Therapeutics<\/td>\n<td>(VERV)<\/td>\n<td>229.2%<\/td>\n<td>\u533b\u7597<\/td>\n<\/tr>\n<tr>\n<td>2U<\/td>\n<td>(TWOU)<\/td>\n<td>178.0%<\/td>\n<td>\u53ef\u9009\u6d88\u8d39<\/td>\n<\/tr>\n<tr>\n<td>Intellia Therapeutics<\/td>\n<td>(NTLA)<\/td>\n<td>150.4%<\/td>\n<td>\u533b\u7597<\/td>\n<\/tr>\n<tr>\n<td>Invitae<\/td>\n<td>(NVTA)<\/td>\n<td>109.0%<\/td>\n<td>\u533b\u7597<\/td>\n<\/tr>\n<tr>\n<td>Ginkgo Bioworks Holdings<\/td>\n<td>(DNA)<\/td>\n<td>103.6%<\/td>\n<td>\u6750\u6599<\/td>\n<\/tr>\n<tr>\n<td>Cerus<\/td>\n<td>(CERS)<\/td>\n<td>91.0%<\/td>\n<td>\u533b\u7597<\/td>\n<\/tr>\n<tr>\n<td>Beam Therapeutics<\/td>\n<td>(BEAM)<\/td>\n<td>74.9%<\/td>\n<td>\u533b\u7597<\/td>\n<\/tr>\n<tr>\n<td>Archer Aviation<\/td>\n<td>(ACHR)<\/td>\n<td>52.4%<\/td>\n<td>\u5de5\u4e1a<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>\u5728\u534e\u5c14\u8857\u770b\u597d\u7684\u6728\u5934\u59d0\u80a1\u7968\u5f53\u4e2d\uff0c5\u53ea\u90fd\u6765\u81ea\u4e8e\u533b\u7597\u677f\u5757\u4e14\u6295\u673a\u6027\u660e\u663e\uff0c\u5176\u4e2d\u6700\u770b\u597d\u7684\u57fa\u56e0\u7f16\u8f91\u516c\u53f8Verve Therapeutics\u5360ARK Innovation\u7684\u6743\u91cd\u4ec5\u67090.5%\u3002\u5206\u6790\u5e08\u9884\u8ba1\u8be5\u80a1\u80a1\u4ef7\u672a\u676512\u4e2a\u6708\u5c06\u4e0a\u6da8229%\u81f345.89\u7f8e\u5143\u3002\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0cVerve\u80a1\u4ef72023\u5e74\u4e0b\u8dcc28%\uff0c\u53bb\u5e74\u6bcf\u80a1\u4e8f\u635f3.26\u7f8e\u5143\uff0c\u5e76\u4e14\u5206\u6790\u5e08\u9884\u8ba1\u8be5\u516c\u53f8\u81f3\u5c11\u52302027\u5e74\u4e4b\u524d\u90fd\u65e0\u6cd5\u76c8\u5229\u3002<\/p>\n<p>\u53e6\u4e00\u53ea\u88ab\u5206\u6790\u5e08\u770b\u597d\u7684\u6728\u5934\u59d0\u80a1\u7968\u4e5f\u662f\u4e00\u5bb6\u57fa\u56e0\u7f16\u8f91\u80a1\u7968Intellia Therapeutics\uff0c\u5206\u6790\u5e08\u9884\u8ba1\u8be5\u80a1\u80a1\u4ef7\u4eca\u5e74\u5c06\u4e0a\u6da8\u8d85\u8fc7150%\u3002\u8be5\u80a1\u5360ARK Innovation\u7684\u6743\u91cd\u4e3a2.8%\uff0c\u7a0d\u9ad8\u4e8eVerve\u4f46\u6bd4\u91cd\u4e5f\u4e0d\u9ad8\uff0c\u540c\u65f6\u8be5\u516c\u53f82023\u5e74\u6bcf\u80a1\u4e8f\u635f5.38\u7f8e\u5143\uff0c\u5e76\u4e14\u4e8f\u635f\u72b6\u6001\u5c06\u6301\u7eed\u81f32027\u5e74\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u6728\u5934\u59d0\u7684\u57fa\u91d1ARK Innovation ETF\uff08ARKK\uff09\u4ece\u6765\u4e0d\u60e7\u8ddf\u534e\u5c14\u8857\u548c\u6807\u666e500\u6307\u6570\u5531\u53cd\u8c03\uff0c\u4f46\u6709\u4e9b\u65f6\u5019 [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":403000,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[747,2155,2226,925],"class_list":["post-482237","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-747","tag-2155","tag-2226","tag-925","sectors-1602","sectors-life-science-zh-hans","sectors-technology-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/482237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=482237"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/482237\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/403000"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=482237"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=482237"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=482237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}